Cargando...
Adherence to lenalidomide in older adults with newly-diagnosed multiple myeloma
INTRODUCTION: One of the most common orally administered anti-myeloma agent, lenalidomide, has significantly improved outcomes in multiple myeloma, including in older patients. However, despite its utilization and cost, the rates and factors related to adherence to lenalidomide in older adults with...
Gardado en:
| Publicado en: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564009/ https://ncbi.nlm.nih.gov/pubmed/31843543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.09.618 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|